Stay updated on Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added and Revision: v3.6.3 was removed. This reflects a site-wide update to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-07-27T05:56:46.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Added the revision indicator 'Revision: v3.6.3' in the footer and removed 'Revision: v3.6.2'. This reflects a minor update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-07-05T13:43:20.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page's software revision has been updated from v3.6.0 to v3.6.2, indicating a backend/frontend update. The study content and available information remain the same.
    Difference
    0.1%
    Check dated 2026-06-28T08:26:46.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Recruitment status 'No longer looking for participants' is displayed on the study details page, and new help/navigation sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added. The Intervention/Treatment header is updated, and the revision tag now shows v3.6.0, replacing the previous v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-14T06:21:41.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The page revision stamp was updated to v3.5.5, replacing the previous v3.5.4. This appears to be a backend or CMS update rather than a change to study information or features.
    Difference
    0.1%
    Check dated 2026-06-07T03:11:22.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    The revision label has been updated from v3.5.3 to v3.5.4, signaling a system update. This change does not alter the study content or its presented details.
    Difference
    0.1%
    Check dated 2026-05-16T09:25:24.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.